Shilpa Medicare Limited (SHILPAMED)
₹864.65
INR-26.15(-2.94%)
As of December 5, 2024 4:08:00 AMShilpa Medicare Limited Share Price Information
24 hour Low and High
The lowest and highest prices reached in the last 24 hours of trading
Low: ₹862.3
High: ₹894.15
All time High
The highest price the stock has ever reached since being listed
₹7796.26
Price Change 1h
Price change in the last hour of trading
+₹-26.15 +-2.94%
Price Change 1d
Price change over the last trading day
+₹-26.15 +-2.94%
Price Change 1w
Price change over the last week of trading
+₹-8.60 +-0.98%
Shilpa Medicare Limited Market Information
Exchange
The Exchange where the trading of the stock takes place
NSE
Market Cap
The current market capitalisation of the stock
8261.98 Cr
About Shilpa Medicare Limited Share
Shilpa Medicare Limited, together with its subsidiaries, manufactures and sells active pharmaceutical ingredients (APIs), finished dosage formulations, biosimilars, recombinant albumin in India, the United States, Europe, and internationally. The company offers various oncology and non-oncology APIs, such as anastrozole, acebrophylline, ambroxol hydrochloride, axitinib, azacitidine, abiraterone acetate, bendamustine HCL monohydrate, bicalutamide, bortezomib, busulphan, cabazitaxel amorphous, capecitabine, clofarabine, cyclophosphamide, dasatinib, decitabine, dimethyl fumarate, erlotinib HCL, enzalutamide, fingolimod hydrochloride, gemcitabine HCl, ibrutinib, imatinib mesylate, irinotecan HCl trihydrate, lenalidomide, lenvatinib mesylate, letrozole, and melphalan HCL. Its APIs also include nifedipine, oxaliplatin, pazopanib, pemetrexed disodium hemipentahydrate, pemetrexed dipotassium nonahydrate, pirfenidone, pomalidomide, sodium cholesteryl sulfate, sorafenib tosylate, sunitinib malate, temozolomide, teriflunomide, thalidomide, tranexamic and zoledronic acid, phenylephrine, citicholine, palbocicilib, nilotinib, nintedanib, praziquintol, carmustine, elthrombopag olamine, abacavir sulphate, tenofovir disproxyl fumarate API, tenofovir alfanamide, prucalopride succinate, and varenicline tartrate. In addition, the company provides intermediates; high-purity multi-cyclic and long-chain peptides; specialty and biopolymers; biologics; contract development and manufacturing services; and formulations, such as tablets, capsules, liquid injections, dry powder injectable products, orally disintegrating films, transdermal patches, and lyophilized injectables. Further, it is involved in the manufacture of specialized oncology formulations; and wind power generation activities. The company was formerly known as Shilpa Antibiotics Ltd and changed its name to Shilpa Medicare Limited in February 2003. Shilpa Medicare Limited was incorporated in 1987 and is based in Raichur, India.
Sector
Healthcare
Drug Manufacturers - Specialty & Generic
Employees
about
1007
CEO
Revenue (2023)
%
Country of Origin
India
Key Highlights
- Shilpa Medicare Limited (NSE:SHILPAMED) Stock Is Going Strong But Fundamentals Look Uncertain: What Lies Ahead ?
- What Shilpa Medicare Limited's (NSE:SHILPAMED) 28% Share Price Gain Is Not Telling You
- Shilpa Medicare shares hit 52-week high on prospects of a huge order; check details
- Shilpa Medicare Ltd Share Price Today, SHILPAMED Share Price NSE, BSE
- Investors more bullish on Shilpa Medicare (NSE:SHILPAMED) this week as stock swells 11%, despite earnings trending downwards over past five years
Shilpa Medicare Limited Resource
FAQs
The current price of Shilpa Medicare Limited is INR 864.65 — it has changed by -2.94% in the past 24 hours. Watch Shilpa Medicare Limited's stock price performance more closely on the chart.
Shilpa Medicare Limited has a market capitalization of 82619777024 as of today.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Shilpa Medicare Limited's EBITDA is INR undefined
Depending on the exchange, the stock ticker may vary. For instance, on NSE exchange Shilpa Medicare Limited stocks are traded under the ticker [object Object]
As of December 05, 2024, the company has 1007 employees.